Cargando…

Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis

Contrasting data exist on the effect of gender and menopause on the susceptibility, development and liver damage progression in non-alcoholic fatty liver disease (NAFLD). Our aim was to assess whether menopause is associated with the severity of liver fibrosis in individuals with NAFLD and to explor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Turola, Elena, Petta, Salvatore, Vanni, Ester, Milosa, Fabiola, Valenti, Luca, Critelli, Rosina, Miele, Luca, Maccio, Livia, Calvaruso, Vincenza, Fracanzani, Anna L., Bianchini, Marcello, Raos, Nazarena, Bugianesi, Elisabetta, Mercorella, Serena, Di Giovanni, Marisa, Craxì, Antonio, Fargion, Silvia, Grieco, Antonio, Cammà, Calogero, Cotelli, Franco, Villa, Erica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Company of Biologists 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4582103/ https://www.ncbi.nlm.nih.gov/pubmed/26183212 http://dx.doi.org/10.1242/dmm.019950

Ejemplares similares

Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver Disease
por: Pelusi, Serena, et al.
Publicado: (2016)

Glucokinase Regulatory Protein Gene Polymorphism Affects Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
por: Petta, Salvatore, et al.
Publicado: (2014)

Obese zebrafish: A small fish for a major human health condition
por: Faillaci, Francesca, et al.
Publicado: (2018)

NT Pro BNP Plasma Level and Atrial Volume Are Linked to the Severity of Liver Cirrhosis
por: Licata, Anna, et al.
Publicado: (2013)

PNPLA3 GG Genotype and Carotid Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease
por: Petta, Salvatore, et al.
Publicado: (2013)

Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease
por: Donati, Benedetta, et al.
Publicado: (2017)

MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals
por: Donati, Benedetta, et al.
Publicado: (2017)

Gallstone Disease Is Associated with More Severe Liver Damage in Patients with Non-Alcoholic Fatty Liver Disease
por: Fracanzani, Anna Ludovica, et al.
Publicado: (2012)

Serum γ-glutamyl Transferase Levels, Insulin Resistance and Liver Fibrosis in Patients with Chronic Liver Diseases
por: Petta, Salvatore, et al.
Publicado: (2012)

Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease
por: Pennisi, Grazia, et al.
Publicado: (2023)

Protein phosphatase 1 regulatory subunit 3B gene variation protects against hepatic fat accumulation and fibrosis in individuals at high risk of nonalcoholic fatty liver disease
por: Dongiovanni, Paola, et al.
Publicado: (2018)

Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
por: Pelusi, Serena, et al.
Publicado: (2019)

Insulin resistance and hyperandrogenism drive steatosis and fibrosis risk in young females with PCOS
por: Petta, Salvatore, et al.
Publicado: (2017)

Therapeutic algorithms for chronic hepatitis C in the DAA era during the current economic crisis: whom to treat? How to treat? When to treat?
por: Petta, Salvatore, et al.
Publicado: (2012)

Liver and cardiovascular mortality after hepatitis C virus eradication by DAA: Data from RESIST‐HCV cohort
por: Calvaruso, Vincenza, et al.
Publicado: (2021)

Microenvironment inflammatory infiltrate drives growth speed and outcome of hepatocellular carcinoma: a prospective clinical study
por: Critelli, Rosina, et al.
Publicado: (2017)

Pathophysiology of Non Alcoholic Fatty Liver Disease
por: Petta, Salvatore, et al.
Publicado: (2016)

Obstructive Sleep Apnea Is Associated with Liver Damage and Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease
por: Petta, Salvatore, et al.
Publicado: (2015)

Mer Tyrosine Kinase (MERTK) modulates liver fibrosis progression and hepatocellular carcinoma development
por: Pipitone, Rosaria Maria, et al.
Publicado: (2022)

Lack of association between peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms and progressive liver damage in patients with non-alcoholic fatty liver disease: a case control study
por: Dongiovanni, Paola, et al.
Publicado: (2010)

Nonalcoholic Fatty Liver Disease (NAFLD) as Model of Gut–Liver Axis Interaction: From Pathophysiology to Potential Target of Treatment for Personalized Therapy
por: Fianchi, Francesca, et al.
Publicado: (2021)

Heart rate variability is associated with disease severity and portal hypertension in cirrhosis
por: Miceli, Giuseppe, et al.
Publicado: (2023)

Liver transplantation for intermediate hepatocellular carcinoma: An adaptive approach
por: Biolato, Marco, et al.
Publicado: (2017)

A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease
por: Pennisi, Grazia, et al.
Publicado: (2022)

Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation
por: Lasagni, Simone, et al.
Publicado: (2022)

Genetic variation in the TLL1 gene is not associated with fibrosis in patients with metabolic associated fatty liver disease
por: Bayoumi, Ali, et al.
Publicado: (2020)

Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access program
por: Calvaruso, Vincenza, et al.
Publicado: (2019)

Reproductive Status Is Associated with the Severity of Fibrosis in Women with Hepatitis C
por: Villa, Erica, et al.
Publicado: (2012)

Optimizing Sequential Systemic Therapies for Advanced Hepatocellular Carcinoma: A Decision Analysis
por: Cabibbo, Giuseppe, et al.
Publicado: (2020)

Progression-Free Survival Early Assessment Is a Robust Surrogate Endpoint of Overall Survival in Immunotherapy Trials of Hepatocellular Carcinoma
por: Cabibbo, Giuseppe, et al.
Publicado: (2020)

miRNA Signature in NAFLD: A Turning Point for a Non-Invasive Diagnosis
por: Dongiovanni, Paola, et al.
Publicado: (2018)

Nutrients, Genetic Factors, and Their Interaction in Non-Alcoholic Fatty Liver Disease and Cardiovascular Disease
por: Lombardi, Rosa, et al.
Publicado: (2020)

Genetics, Immunity and Nutrition Boost the Switching from NASH to HCC
por: Dongiovanni, Paola, et al.
Publicado: (2021)

Upper Limits of Downstaging for Hepatocellular Carcinoma in Liver Transplantation
por: Biolato, Marco, et al.
Publicado: (2021)

A single course of lusutrombopag for multiple invasive procedures in cirrhosis-associated thrombocytopenia: A case series
por: Biolato, Marco, et al.
Publicado: (2022)

Two elective invasive procedures after a single avatrombopag treatment in a patient with liver cirrhosis and severe thrombocytopenia
por: Biolato, Marco, et al.
Publicado: (2022)

Upregulation of the oestrogen target gene SIX1 is associated with higher growth speed and decreased survival in HCV-positive women with hepatocellular carcinoma
por: Critelli, Rosina Maria, et al.
Publicado: (2022)

Cardiovascular risk after orthotopic liver transplantation, a review of the literature and preliminary results of a prospective study
por: Pisano, Giuseppina, et al.
Publicado: (2016)

Branched chain amino acids in hepatic encephalopathy and sarcopenia in liver cirrhosis: Evidence and uncertainties
por: Marrone, Giuseppe, et al.
Publicado: (2023)

The Presence of White Matter Lesions Is Associated With the Fibrosis Severity of Nonalcoholic Fatty Liver Disease
por: Petta, Salvatore, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_f2fbld0n3lrbvhakpcqu9nbfc5